Publications by authors named "Mark Biondo"

Claim this Profile
T
Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease.
Kevin Ming-Chin Lee, Tanya Lupancu, Stacey N Keenan, Georgina Bing, Adrian A Achuthan, Mark Biondo

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice.
Heonsu Shin, Varun Prasad, Tanya Lupancu, Shveta Malik, Adrian Achuthan, Mark Biondo

Osteoarthritis Cartilage· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312).
Dipti Pawaskar, Xi Chen, Fiona Glassman, Frauke May, Anthony Roberts, Mark Biondo

Clin Transl Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.
Amy K Searle, Yung-Chih Chen, Maria Wallert, James D McFadyen, Ana C Maluenda, Mark Biondo

Thromb Haemost· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation.
Helen Cao, Mark Biondo, Hadi Lioe, Samantha Busfield, Veronika Rayzman

J Allergy Clin Immunol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus.
Shereen Oon, Huy Huynh, Tsin Yee Tai, Milica Ng, Katherine Monaghan, Mark Biondo

JCI Insight· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.
Eva Nievergall, Hayley S Ramshaw, Agnes S M Yong, Mark Biondo, Samantha J Busfield

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.
Robyn E O'Hehir, Leanne M Gardner, Maria P de Leon, Belinda J Hales, Mark Biondo

Am J Respir Crit Care Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing the autoimmune condition: experience with experimental autoimmune gastritis.
Frank Alderuccio, Kim Murphy, Mark Biondo, Judith Field, Ban-Hock Toh

Int Rev Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance established in autoimmune disease by mating or bone marrow transplantation that target autoantigen to thymus.
Kim Murphy, Mark Biondo, Ban-Hock Toh, Frank Alderuccio

Int Immunol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific autoimmunity in granulocyte macrophage-colony stimulating factor (GM-CSF) deficient mice.
Frank Alderuccio, Mark Biondo, Ban-Hock Toh

Autoimmunity· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of human disease: experimental autoimmune gastritis--a model for autoimmune gastritis and pernicious anemia.
Frank Alderuccio, John W Sentry, Aiden C J Marshall, Mark Biondo, Ban Hock Toh

Clin Immunol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis